| Dr Glen A Curda, DPM | |
|
2950 Northup Way, Suite 115, Bellevue, WA 98004-1406 | |
| (425) 893-8100 | |
| (425) 893-8111 |
| Full Name | Dr Glen A Curda |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 46 Years |
| Location | 2950 Northup Way, Bellevue, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760446611 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 301 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Metroliance Foot And Ankle Group | 5698084564 | 2 |
News Archive
Researchers at University College London have identified a rare gene mutation in an Italian family who have little sensitivity to some forms of pain. Chronic pain caused by conditions such as lower back pain and osteoarthritis is one of the most prominent causes of disability worldwide, as assessed by the Global Burden of Disease reviews.
Dyadic International, Inc. a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has been issued U.S. Patent No. 7,794,962 by the United States Patent and Trademark Office.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced the publication of new data in the journal Nature Biotechnology by Alnylam scientists and collaborators from Tekmira Pharmaceuticals Corporation, AlCana Technologies, Inc., and The University of British Columbia (UBC). The new study employed a rational design approach for the discovery of novel lipids that can be incorporated into lipid nanoparticles (LNPs) for systemic delivery of RNAi therapeutics.
The beneficial effects of anti-angiogenesis drugs in the treatment of the deadly brain tumors called glioblastomas appear to result primarily from reduction of edema - the swelling of brain tissue - and not from any direct anti-tumor effect, according to a study from Massachusetts General Hospital (MGH) researchers.
› Verified 1 days ago
| Provider Name | Metroliance Foot And Ankle Group |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1750796579 PECOS PAC ID: 5698084564 Enrollment ID: O20151020002744 |
News Archive
Researchers at University College London have identified a rare gene mutation in an Italian family who have little sensitivity to some forms of pain. Chronic pain caused by conditions such as lower back pain and osteoarthritis is one of the most prominent causes of disability worldwide, as assessed by the Global Burden of Disease reviews.
Dyadic International, Inc. a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has been issued U.S. Patent No. 7,794,962 by the United States Patent and Trademark Office.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced the publication of new data in the journal Nature Biotechnology by Alnylam scientists and collaborators from Tekmira Pharmaceuticals Corporation, AlCana Technologies, Inc., and The University of British Columbia (UBC). The new study employed a rational design approach for the discovery of novel lipids that can be incorporated into lipid nanoparticles (LNPs) for systemic delivery of RNAi therapeutics.
The beneficial effects of anti-angiogenesis drugs in the treatment of the deadly brain tumors called glioblastomas appear to result primarily from reduction of edema - the swelling of brain tissue - and not from any direct anti-tumor effect, according to a study from Massachusetts General Hospital (MGH) researchers.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Glen A Curda, DPM 2040 156th Ave Se, Bellevue, WA 98007-6300 Ph: (425) 746-5996 | Dr Glen A Curda, DPM 2950 Northup Way, Suite 115, Bellevue, WA 98004-1406 Ph: (425) 893-8100 |
News Archive
Researchers at University College London have identified a rare gene mutation in an Italian family who have little sensitivity to some forms of pain. Chronic pain caused by conditions such as lower back pain and osteoarthritis is one of the most prominent causes of disability worldwide, as assessed by the Global Burden of Disease reviews.
Dyadic International, Inc. a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has been issued U.S. Patent No. 7,794,962 by the United States Patent and Trademark Office.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced the publication of new data in the journal Nature Biotechnology by Alnylam scientists and collaborators from Tekmira Pharmaceuticals Corporation, AlCana Technologies, Inc., and The University of British Columbia (UBC). The new study employed a rational design approach for the discovery of novel lipids that can be incorporated into lipid nanoparticles (LNPs) for systemic delivery of RNAi therapeutics.
The beneficial effects of anti-angiogenesis drugs in the treatment of the deadly brain tumors called glioblastomas appear to result primarily from reduction of edema - the swelling of brain tissue - and not from any direct anti-tumor effect, according to a study from Massachusetts General Hospital (MGH) researchers.
› Verified 1 days ago
Molly Ichikawa, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 1609 116th Ave Ne, Bellevue, WA 98004 Phone: 425-283-5093 | |
Bellevue Podiatry Inc. Podiatrist Medicare: Medicare Enrolled Practice Location: 1370 116th Ave Ne, Ste. 206, Bellevue, WA 98004 Phone: 425-450-0565 Fax: 425-462-1742 | |
Careplus Foot And Ankle Specialists Podiatrist Medicare: Medicare Enrolled Practice Location: 12737 Bel Red Rd, Suite 200, Bellevue, WA 98005 Phone: 425-455-0936 Fax: 425-462-8080 | |
Hubert W Lee, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 12737 Bel-red Rd, Suite 200, Bellevue, WA 98005 Phone: 425-455-0936 Fax: 425-462-8080 | |
Mr. Douglas J Ichikawa, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1609 116th Ave Ne, Bellevue, WA 98004 Phone: 425-283-5093 Fax: 425-283-5095 | |
Pro Sports Club Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4455 148th Ave Ne, Bellevue, WA 98007 Phone: 425-895-6546 Fax: 425-861-6277 | |
Dr. Jason H Kim, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 Fax: 425-502-3589 |